ArticleThrombosis journal2021

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19.

David Oliver Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.